Svlg Newgen Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -132666.67%
- Ebitda -132666.67%
- Net Worth -23.90%
- Total Assets -12.10%
About Svlg Newgen Pharma
Svlg Newgen Pharma Private Limited (SNPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 May 2021 (Three years and eight months 8 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jagadeshwar Madhavaram and Pampana Suhas serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230TG2021PTC151706
- Company No.
151706
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2021
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Svlg Newgen Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagadeshwar Madhavaram  | Director | 14-Oct-2022 | Current |
| Pampana Suhas | Director | 24-May-2021 | Current |
Financial Performance of Svlg Newgen Pharma.
Svlg Newgen Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 132666.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svlg Newgen Pharma?
Unlock access to Svlg Newgen Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ssev Bio Sciences Private LimitedPampana Suhas is a mutual person
- Ssev Solar Power Private Limited
Pampana Suhas is a mutual person
- Ssev Software Solutions Private Limited
Pampana Suhas is a mutual person
Avaneendra Constructions LlpJagadeshwar Madhavaram is a mutual person
- Avalon Builders Private Limited
Jagadeshwar Madhavaram is a mutual person
- Konstruct Realty India Private Limited
Jagadeshwar Madhavaram is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Svlg Newgen Pharma?
Svlg Newgen Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svlg Newgen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svlg Newgen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
